Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue
- 1 August 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 956, 175942
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- What We Talk About When We Talk About FatCell, 2014
- AMP-activated protein kinase: A target for old drugs against diabetes and cancerBiochemical Pharmacology, 2013
- Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in miceBiochemical Pharmacology, 2010
- Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-ζ Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial CellsCirculation, 2008
- Adipocyte differentiation from the inside outNature Reviews Molecular Cell Biology, 2006
- Alisol B acetate, a triterpene from Alismatis rhizoma, induces Bax nuclear translocation and apoptosis in human hormone-resistant prostate cancer PC-3 cellsCancer Letters, 2006
- Obesity as a disease: no lightweight matterObesity Reviews, 2004
- Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic SyndromeEndocrine Reviews, 2000
- Molecular regulation of adipocyte differentiationSeminars in Cell & Developmental Biology, 1999
- Transcription, adipocyte differentiation, and obesityJournal of Molecular Medicine, 1996